Alcohol Consumption, High-Density Lipoprotein Particles and Subspecies, and Risk of Cardiovascular Disease: Findings from the PREVEND Prospective Study

被引:3
|
作者
Kunutsor, Setor K. [1 ]
Bhattacharjee, Atanu [2 ]
Connelly, Margery A. [3 ]
Bakker, Stephan J. L. [4 ]
Dullaart, Robin P. F. [5 ]
机构
[1] Univ Leicester, Diabet Res Ctr, Leicester Real World Evidence Unit, Leicester LE5 4WP, England
[2] Univ Dundee, Div Populat Hlth & Genom, Dundee DD1 4HN, Scotland
[3] Labcorp, Morrisville, NC 27560 USA
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, POB 30001, NL-9700 RB Groningen, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Endocrinol, POB 30001, NL-9700 RB Groningen, Netherlands
关键词
HDL cholesterol; HDL particles; HDL subspecies; alcohol consumption; cardiovascular disease; cohort study; CHOLESTERYL ESTER TRANSFER; CATALYTIC ACTIVITY CONCENTRATIONS; TRANSFER PROTEIN-ACTIVITY; INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; EVENTS; METABOLISM; CETP; ACYLTRANSFERASE;
D O I
10.3390/ijms25042290
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The associations of HDL particle (HDL-P) and subspecies concentrations with alcohol consumption are unclear. We aimed to evaluate the interplay between alcohol consumption, HDL parameters and cardiovascular disease (CVD) risk. In the PREVEND study of 5151 participants (mean age, 53 years; 47.5% males), self-reported alcohol consumption and HDL-P and subspecies (small, medium, and large) by nuclear magnetic resonance spectroscopy were assessed. Hazard ratios (HRs) with 95% CIs for first CVD events were estimated. In multivariable linear regression analyses, increasing alcohol consumption increased HDL-C, HDL-P, large and medium HDL, HDL size, and HDL subspecies (H3P, H4P, H6 and H7) in a dose-dependent manner. During a median follow-up of 8.3 years, 323 first CVD events were recorded. Compared with abstainers, the multivariable adjusted HRs (95% CIs) of CVD for occasional to light, moderate, and heavy alcohol consumers were 0.72 (0.55-0.94), 0.74 (0.54-1.02), and 0.65 (0.38-1.09), respectively. These associations remained consistent on additional adjustment for each HDL parameter. For CVD, only HDL-C was associated with a statistically significant decreased risk of CVD in a fully adjusted analysis (HR 0.84, 95% CI 0.72-0.97 per 1 SD increment). For coronary heart disease, HDL-C, HDL-P, medium HDL, HDL size, and H4P showed inverse associations, whereas HDL-C and HDL size modestly increased stroke risk. Except for H6P, alcohol consumption did not modify the associations between HDL parameters and CVD risk. The addition of HDL-C, HDL size, or H4P to a CVD risk prediction model containing established risk factors improved risk discrimination. Increasing alcohol consumption is associated with increased HDL-C, HDL-P, large and medium HDL, HDL size, and some HDL subspecies. Associations of alcohol consumption with CVD are largely independent of HDL parameters. The associations of HDL parameters with incident CVD are generally not attenuated or modified by alcohol consumption.
引用
收藏
页数:23
相关论文
共 50 条
  • [31] Reducing cardiovascular risk by targeting high-density lipoprotein cholesterol
    Toth P.P.
    Current Atherosclerosis Reports, 2007, 9 (1) : 81 - 88
  • [32] The importance of high-density lipoprotein cholesterol in the management of cardiovascular risk
    Maritz, FJ
    SOUTH AFRICAN MEDICAL JOURNAL, 2000, 90 (03): : 232 - 233
  • [33] Examining the paradox of high high-density lipoprotein and elevated cardiovascular risk
    Singh, Kavisha
    Rohatgi, Anand
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 109 - 112
  • [34] Cardiovascular risk factors in patients with elevated high-density lipoprotein and coronary artery disease
    DeFaria, DE
    Grant, RW
    CIRCULATION, 2005, 111 (14) : E241 - E241
  • [35] Low high-density lipoprotein cholesterol and cardiovascular disease: Risk reduction with statin therapy
    Rosenson, RS
    AMERICAN HEART JOURNAL, 2006, 151 (03) : 556 - 563
  • [36] Modification of high-density lipoprotein cholesterol in the management of cardiovascular risk
    Koeller, J
    Talbert, RL
    PHARMACOTHERAPY, 2002, 22 (10): : 1266 - 1277
  • [37] High-density lipoprotein levels and risk of cardiovascular events: a review
    Mureddu, Gian Francesco
    Brandimarte, Filippo
    De Luca, Leonardo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2012, 13 (09) : 575 - 586
  • [38] High-Density Lipoprotein and Cardiovascular Risk Reduction: Promises and Realities
    Santos-Gallego, Carlos G.
    Badimon, Juan Jose
    REVISTA ESPANOLA DE CARDIOLOGIA, 2012, 65 (04): : 305 - 308
  • [39] Hepatic Lipase, Genetically Elevated High-Density Lipoprotein, and Risk of Ischemic Cardiovascular Disease
    Johannsen, Trine Holm
    Kamstrup, Pia R.
    Andersen, Rolf V.
    Jensen, Gorm B.
    Sillesen, Henrik
    Tybaerg-Hansen, Anne
    Nordestgaard, Borge G.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (04): : 1264 - 1273
  • [40] THE VALUE OF MEASURING PERCENT HIGH-DENSITY LIPOPROTEIN IN ASSESSING RISK OF CARDIOVASCULAR-DISEASE
    LIPINSKA, I
    GUREWICH, V
    ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (03) : 469 - 472